Teresa Lozano

9PUBLICATIONS
113CO-AUTHORS
Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 24, 2026
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

|May 08, 2026
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

|Sep 19, 2025
Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.

Flor Navarro, Teresa Lozano, Andrea Fuentes-García

|Jun 13, 2023
PTEN Loss Confers Resistance to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells.

Francisco Exposito, Miriam Redrado, Maeva Houry

|Sep 30, 2022
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome.

Paula Rodriguez-Marquez, Maria E Calleja-Cervantes, Guillermo Serrano

|Sep 30, 2022
BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis.

Charlotte J Imianowski, Sarah K Whiteside, Teresa Lozano

Pageof 2

Frequent Collaborators

8 joint publications

Juan José Lasarte

4 joint publications

Felipe Prosper

3 joint publications

Noelia Casares

3 joint publications

Juan Roberto Rodriguez-Madoz